Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anruikefon for multimodal postoperative analgesia after laparoscopic hepatectomy
ChiCTR2600130787Phase 4Not yet recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Aug 2026
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of hsk21542 in acute pain (3 arms), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoint: Consumption of sufentanil via PCIA within 48 h after the first study drug administration. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
hsk21542
03
Conditions
acute pain
Beyond the preview
Go deeper on ChiCTR2600130787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600130787.